Eli Lilly & Co. Reports Third Quarter with $1.18 EPS, Downgrades Guidance

Eli Lilly & Co. reported its results for the third quarter of 2024, with revenue up 20% y/y but failing to meet market expectations. The post Eli Lilly & Co. Reports Third Quarter with $1.18 EPS, Downgrades Guidance appeared first on Tokenist. source: https://tokenist.com/eli-lilly-co-reports-third-quarter-with-1-18-eps-downgrades-guidance/?utm_source=rss&utm_medium=rss&utm_campaign=eli-lilly-co-reports-third-quarter-with-1-18-eps-downgrades-guidance